Vol 13, No 6 (June 30, 2024): Translational Lung Cancer Research

Original Article

The impact of different modalities of chemoradiation therapy and chemotherapy regimens on lymphopenia in patients with locally advanced non-small cell lung cancer
Yaqi Li, Xingwen Fan, Yulei Pei, Qi Yu, Renquan Lu, Guoliang Jiang, Kailiang Wu
Segmentectomy versus lobectomy for ground-glass opacity dominant cT1N0 invasive lung adenocarcinoma
Zelin Ma, Yang Zhang, Han Han, Shengping Wang, Yuan Li, Haiquan Chen
Association between strenuous sports or other exercises and lung cancer risk: a mendelian randomization study
Wushu Chen, Anlin Liu, Yu Jiang, Yuechun Lin, Xingpei Li, Chongde Pan, Yixuan Wang, Huiwen Yu, Yulin Zhao, Junxing Li, Hengrui Liang, Runchen Wang, Wei Wang, Xin Xu, Ying Huang
Clinical impact of EGFR and KRAS mutations in surgically treated unifocal and multifocal lung adenocarcinoma
Jiahao Jiang, Mark F. Berry, Natalie S. Lui, Douglas Z. Liou, Winston L. Trope, Leah M. Backhus, Joseph B. Shrager
Predicting MET exon 14 skipping mutation in pulmonary sarcomatoid carcinoma by whole-tumour texture analysis combined with clinical and conventional contrast-enhanced computed tomography features
Lei Miao, Tian Qiu, Yan Li, Jianwei Li, Xu Jiang, Mengwen Liu, Xue Zhang, Jiuming Jiang, Huanhuan Zhang, Yanmei Wang, Xiao Li, Jianming Ying, Meng Li
Predictive value of delta-radiomic features for prognosis of advanced non-small cell lung cancer patients undergoing immune checkpoint inhibitor therapy
Xiaoyu Han, Yujin Wang, Xi Jia, Yuting Zheng, Chengyu Ding, Xiaohui Zhang, Kailu Zhang, Yunkun Cao, Yumin Li, Liming Xia, Chuansheng Zheng, Jing Huang, Heshui Shi
Heterogeneity of lymphocyte subsets in predicting immune checkpoint inhibitor treatment response in advanced lung cancer: an analysis across different pathological types, therapeutic drugs, and age groups
Chuanwang Miao, Yuanji Chen, Hao Zhang, Wei Zhao, Cunliang Wang, Zeliang Ma, Shan Zhu, Xudong Hu
Bioinformatics analysis of an immunotherapy responsiveness-related gene signature in predicting lung adenocarcinoma prognosis
Yupeng Jiang, Bacha Hammad, Hong Huang, Chenzi Zhang, Bing Xiao, Linxia Liu, Qimi Liu, Hengxing Liang, Zhenyu Zhao, Yawen Gao
Correlation analysis between driver gene mutation and clinicopathological features in lung adenocarcinoma based on real-world cumulative clinical data
Sheng Lu, Aotian Guo, Haichuan Hu, Xinxin Ying, Yao Li, Zhengwei Huang, Wangjue Xu, Shen Tao, Xiaotong Hu, Na Yan, Xuan Zhang, Dan Shen, Takaaki Sasaki, Surein Arulananda, Ken Onodera, Zhengfu He
The prognostic role of albumin levels in lung cancer patients receiving third-line or advanced immunotherapy: a retrospective study
Yanfei Chen, Tong Liu, Hui Feng, Tiantian Liu, Jing Zhang, Jun Wang, Jihong Lu, Antonio Rossi, Ivy Riano, Pingping Hu, Jiandong Zhang
Predicting complication risks after sleeve lobectomy for non-small cell lung cancer
Yiming He, Lin Huang, Jiajun Deng, Yifan Zhong, Tao Chen, Yunlang She, Lei Jiang, Deping Zhao, Dong Xie, Gening Jiang, Stefano Bongiolatti, Mara B. Antonoff, René Horsleben Petersen, Chang Chen
PSME3 promotes lung adenocarcinoma development by regulating the TGF-β/SMAD signaling pathway
Shuai Wang, Yongmeng Li, Kai Jin, Kenichi Suda, Rongyang Li, Huiying Zhang, Hui Tian
Peptidyl-prolyl isomerase F as a prognostic biomarker associated with immune infiltrates and mitophagy in lung adenocarcinoma
Zitong Feng, Lin Yuan, Luyuan Ma, Wenhao Yu, Fayez Kheir, Lukas Käsmann, Wolfgang M. Brueckl, Kai Jin, Dingxin Wang, Yi Shen, Rongyang Li, Hui Tian
Tumor mutation burden and FAT3 mutation influence long-term survival in surgically resected small cell lung cancer
Xinyu Qian, Lin Zhu, Na Han, Jing Qin
Pathological and imaging features of pulmonary invasive mucinous adenocarcinoma—a retrospective cohort study
Xinfu Pan, Renxiu Fang, Binjie Zhang, Zhijun Chen, Shanhua Zhang, Hanbo Le, Helmut H. Popper, Lu Liu, Yongkui Zhang